Bipolar disorders are a complex group of severe and chronic disorders that includes bipolar
I disorder, defined by the presence of a syndromal, manic episode, and bipolar II disorder …

Objective To compare the efficacy and discontinuation of augmentation agents in adult
patients with treatment-resistant depression (TRD). We conducted a systematic review and …

Importance Bipolar II disorder (BDII) is a debilitating condition frequently associated with
difficult-to-treat depressive episodes. Psilocybin has evidence for rapid-acting …

Background Many depressed patients are not able to achieve or sustain symptom remission
despite serial treatment trials–often termed “treatment resistant depression”. A broader …

Como nossas atitudes em relação ao suicídio interferem na prática clínica? Quais
características pessoais e circunstâncias mais se associam ao suicídio? Como estimar o …

Bipolar disorder (BD) is a mood disorder with subtypes characterized by episodes of mania,
hypomania, and/or depression. BD is associated with substantial economic burden, and the …

Das Kompendium der Psychiatrischen Pharmakotherapie liegt jetzt in der 14. Auflage vor.
Es ist in der Nachfolge der Psychiatrischen Pharmakotherapie, die von 1974–1996 in …

Abstract Objectives The 2018 Canadian Network for Mood and Anxiety Treatments
(CANMAT) and International Society for Bipolar Disorders (ISBD) guidelines provided …

Resistance to pharmacological agents is commonly encountered in the treatment of acute
episodes of mania. In contemporary practice guidelines, electroconvulsive therapy (ECT) …

Background Resistant bipolar disorder is a major mental health problem related to
significant disability and overall cost. The aim of the current study was to perform a …